ArticleCancer management and research2025
Survival Benefits of Transarterial Chemoembolization Plus Ablation Therapy in Patients With Intermediate or Advanced Hepatocellular Carcinoma: A Propensity Score Matching Study.
Jingyi Dai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.